During the past decade, Holy Spirit Cardiovascular Institute conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Holy Spirit Cardiovascular Institute" #1 sponsor was "Atrium Medical Corporation" with 1 trials, followed by "Philips Clinical & Medical Affairs Global" with 1 trials sponsored, "TherOx" with 1 trials sponsored, "TriReme Medical, LLC" with 1 trials sponsored and "W.L.Gore & Associates" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Holy Spirit Cardiovascular Institute" are "Anterior Wall Acute Myocardial Infarction" (1 trials), "Intermittent Claudication" (1 trials), "Ischemia" (1 trials), "Peripheral Arterial Disease" (1 trials) and "Peripheral Artery Disease" (1 trials). Many other conditions were trialed in "Holy Spirit Cardiovascular Institute" in a lesser frequency.

Most popular intervention types in "Holy Spirit Cardiovascular Institute" are "Device" (5 trials). Other intervention types were less common.

The name of intervention was led by "Chocolate Touch" (1 trials), "Lutonix Drug Coated Balloon" (1 trials), "SSO2 Therapy" (1 trials), "Stenting of the Common and/or External Iliac Arteries" (1 trials) and "Tack Endovascular System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Holy Spirit Cardiovascular Institute" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Holy Spirit Cardiovascular Institute". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Holy Spirit Cardiovascular Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Holy Spirit Cardiovascular Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".